US 10195236
Use of gram negative species to treat atopic dermatitis
granted A61KA61K35/74A61K9/0014
Quick answer
US patent 10195236 (Use of gram negative species to treat atopic dermatitis) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K35/74, A61K9/0014, A61K9/06, A61P